Search - tctmd.com

Displaying 241 - 260 of 609

Sort: Relevancy | Date

Presentation TVT 2022

The DurAVR™ Single-Piece 3D Leaflet TAVR Technology

Presenter: Christopher Meduri

June 09, 2022

Presentation TVT 2022

The Foldax Tria Valve: The Journey to the Promise of a Durable Polymer Valve

Presenter: Steven Yakubov

June 09, 2022

Presentation TVT 2022

The HLT Meridian System: Program Update

Presenter: Satya Shreenivas

June 09, 2022

Presentation TVT 2022

Post-TMVR PVL: Predisposing Factors, Novel Devices, and Management Techniques

Presenter: Isida Byku

June 09, 2022

Presentation TVT 2022

Cardiovalve TTVR System; a Novel Treatment Option for Patients with Tricuspid Regurgitation (Live in a Box Case)

Presenter: Neil Fam

June 09, 2022

Presentation TVT 2022

Cardiovalve TTVR System; a Novel Technology for Patients with Tricuspid Regurgitation

Presenter: Francesco Maisano

June 09, 2022

Presentation TVT 2022

Flash Proposal: A Novel Bicuspid TAVR Trial in the Modern Era

Presenter: David Cohen

June 08, 2022

Presentation TVT 2022

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials

Presenter: Ashwin Nathan

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Future Developments and Novel Applications

Presenter: Brian O'Neill

June 08, 2022

News Conference News EuroPCR 2022

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Yael L. Maxwell

May 27, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

Presentation Fellows 2022

LAA Closure, PFO Closure, and Other Novel Structural Heart Procedures

Presenter: Torsten Vahl

May 08, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2022

Shelley Wood

May 02, 2022

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

News Daily News

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Yael L. Maxwell

March 09, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

Robert M. Califf Becomes 25th Commissioner of the US FDA

L.A. McKeown

February 15, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Daily News

Lower Costs for TAVI Valves Could Improve Access, Analysis Hints

Yael L. Maxwell

January 24, 2022

News Daily News

‘Home Time’ Validated as TAVI Outcomes Performance Metric

L.A. McKeown

January 11, 2022

Advertisement

The DurAVR™ Single-Piece 3D Leaflet TAVR Technology

The Foldax Tria Valve: The Journey to the Promise of a Durable Polymer Valve

The HLT Meridian System: Program Update

Post-TMVR PVL: Predisposing Factors, Novel Devices, and Management Techniques

Cardiovalve TTVR System; a Novel Treatment Option for Patients with Tricuspid Regurgitation (Live in a Box Case)

Cardiovalve TTVR System; a Novel Technology for Patients with Tricuspid Regurgitation

Flash Proposal: A Novel Bicuspid TAVR Trial in the Modern Era

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials

Heterotopic Tricuspid Valve Replacement: Future Developments and Novel Applications

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

LAA Closure, PFO Closure, and Other Novel Structural Heart Procedures

TCTMD’s Top 10 Most Popular Stories for April 2022

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Robert M. Califf Becomes 25th Commissioner of the US FDA

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Lower Costs for TAVI Valves Could Improve Access, Analysis Hints

‘Home Time’ Validated as TAVI Outcomes Performance Metric

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content